Related Experiment Video
Updated: Aug 20, 2025
10:32
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
3.7K
Retinopathy of prematurity
Olaf Dammann1,2,3, M Elizabeth Hartnett4, Andreas Stahl5
1Tufts University School of Medicine, Department of Public Health & Community Medicine, MA, Boston, USA.
Developmental Medicine and Child Neurology
|November 21, 2022
Summary
Retinopathy of prematurity (ROP) is a serious eye condition in premature infants. Recent advancements include a new classification system and anti-vascular endothelial growth factor (VEGF) treatments, though research into their long-term effects is ongoing.
Area of Science:
- Ophthalmology
- Neonatology
- Developmental Biology
Background:
- Retinopathy of prematurity (ROP) is a significant cause of vision loss in premature infants.
- It is a complex neurovascular disorder affecting retinal development.
Purpose of the Study:
- To provide a concise review of current knowledge on ROP diagnosis, etiology, pathogenesis, intervention, and outcomes.
- To discuss advancements in ROP classification and treatment with anti-VEGF agents.
- To explore the benefits and risks of anti-VEGF therapy and identify future research directions.
Main Methods:
- Literature review and synthesis of current research on ROP.
- Analysis of the International Classification of Retinopathy of Prematurity, Third Edition.
- Evaluation of anti-vascular endothelial growth factor (VEGF) treatment strategies.
Main Results:
- Major advancements include the updated International Classification of ROP, Third Edition.
- Anti-VEGF agents represent a significant new treatment modality for severe ROP.
- Improved understanding of ROP pathophysiology informs treatment decisions.
Conclusions:
- Anti-VEGF therapy offers benefits but also carries risks that require careful consideration.
- Further research is needed to fully understand the long-term implications of anti-VEGF treatment in ROP.
- Continued investigation into ROP pathophysiology and treatment is essential.
Related Concept Videos
01:32The Retina
69.5K
The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
69.5K
01:20The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K